Udvalget for Humanmedicinske Lægemidler (CHMP) konkluderede, at behandling med Evoltra kan give mulighed for at opnå remission og gøre det lettere at transplantere stamceller.
The Committee for Medicinal Products for Human Use (CHMP) concluded that Evoltra treatment may provide a way of obtaining remission, and of facilitating a stem cell transplant.